Endocannabinoid system alterations in Alzheimer’s disease: A systematic review of human studies

•Endocannabinoid system functioning is altered in Alzheimer’s disease.•Expression and activity of CB2R, MAGL and FAAH may be increased in Alzheimer’s disease.•Very few studies included patients with mild cognitive impairment (MCI)•TRPV1 expression appears unaltered in Alzheimer’s disease.•Few studie...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Brain research 2020-12, Vol.1749, p.147135-147135, Article 147135
Hauptverfasser:	Berry, Alex J., Zubko, Olga, Reeves, Suzanne J., Howard, Robert J.
Format:	Artikel
Sprache:	eng
Schlagworte:	2-arachidonoylglycerol Alzheimer Anandamide Cannabinoid receptor Endocannabinoid Fatty acid amide hydrolase Monoacylglycerol Neurodegeneration TRPV1
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!